Herbas VPB

Print
EN | LT
LT - PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING
EN - PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/5575
A61K 45/06
A61P 17/02
A61P 43/00
European patent
(11) Number of the document 3049088
(13) Kind of document T
(96) European patent application number 14824091.4
Date of filing the European patent application 2014-09-26
(97) Date of publication of the European application 2016-08-03
(45) Date of publication and mention of the grant of the patent 2021-02-17
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2014/002746
Date 2014-09-26
PCT application publication
(87) Number WO 2015/044788
Date 2015-04-02
Priority applications
(30) Number Date Country code
201361960740 P 2013-09-26 US
Inventors
(72)
SCHERER, Warren J., US
Grantee
(73) Galderma S.A., World Trade Center Avenue Gratta-Paille 1,, 1000 Lausanne 30 Grey, CH
Title
(54) PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING
  PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING
Last update date 2021-06-30